Using mass cytometry and T cell receptor (TCR) sequencing of colorectal and lung cancer specimens, CD39 expression was enriched in CD8 tumor infiltrating lymphocytes (TILs) that possessed cancer antigen specificity (47). This evidence concerns the gene CD8A and neoplasm.